These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 26437164)

  • 1. Leukemia cutis with lymphoglandular bodies: a clue to acute lymphoblastic leukemia cutis.
    Obiozor C; Ganguly S; Fraga GR
    Dermatol Online J; 2015 Aug; 21(8):. PubMed ID: 26437164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ponatinib-Induced Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia without the T315I Mutation Relapsing after Allogeneic Transplant.
    Petrungaro A; Gentile M; Mazzone C; Greco R; Uccello G; Recchia AG; De Stefano L; Bossio S; Palummo A; Morelli R; Musolino C; Morabito F; Vigna E
    Chemotherapy; 2017; 62(6):353-356. PubMed ID: 28810255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapidly Growing Thyroid Mass: An Unusual Case of Acute Lymphoblastic Leukemia.
    Özdemirkıran F; Oruk G; Payzin B; Gümüş Z; Koruyucu M; Atasever T; Küçükzeybek B; Esen Ö
    Turk J Haematol; 2015 Sep; 32(3):276-8. PubMed ID: 26376596
    [No Abstract]   [Full Text] [Related]  

  • 4. Leukemia cutis in a Ph+ ALL patient treated with ponatinib.
    Pileri A; Papayannidis C; Messori S; Bacci F; Sagramoso CA; Martinelli G; Patrizi A
    G Ital Dermatol Venereol; 2018 Oct; 153(5):730-731. PubMed ID: 30246954
    [No Abstract]   [Full Text] [Related]  

  • 5. Does ponatinib cross the blood-brain barrier?
    Abid MB; De Mel S
    Br J Haematol; 2017 Nov; 179(3):497-498. PubMed ID: 27352067
    [No Abstract]   [Full Text] [Related]  

  • 6. Precursor-B-cell-ALL leukemia cutis resembling lipomas: an atypical presentation of a rare entity and a review of the literature.
    Huang YY; Liu M; Ruth JS; Potenziani S; Hsu S
    Dermatol Online J; 2017 Mar; 23(3):. PubMed ID: 28329516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitors.
    Duployez N; Grzych G; Ducourneau B; Alarcon Fuentes M; Grardel N; Boyer T; Abou Chahla W; Bruno B; Nelken B; Clappier E; Preudhomme C
    Haematologica; 2016 Apr; 101(4):e133-4. PubMed ID: 26681761
    [No Abstract]   [Full Text] [Related]  

  • 8. Dasatinib plus chemotherapy to achieve full donor chimerism and complete molecular remission in a child with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Tamamyan G; Chao YH; Wang CH; Wu HP; Weng T; Peng CT; Wu KH
    Pediatr Blood Cancer; 2013 Oct; 60(10):1727-8. PubMed ID: 23737095
    [No Abstract]   [Full Text] [Related]  

  • 9. Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia.
    Bertamini L; Nanni J; Marconi G; Abbenante M; Robustelli V; Bacci F; Matti A; Paolini S; Sartor C; Monaco SL; Fontana MC; De Polo S; Cavo M; Curti A; Martinelli G; Papayannidis C
    BMC Cancer; 2018 Nov; 18(1):1117. PubMed ID: 30442119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is AP24534 (Ponatinib) the next treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia?].
    Thomas X
    Bull Cancer; 2011 Jul; 98(7):761-7. PubMed ID: 21700550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Favorable outcome with STI571 (imatinib mesylate) and allogeneic stem cell transplantation in a case of Ph+ chemorefractory acute lymphocytic leukaemia.
    Wernstedt P; Brune M; Andersson PO; Gustavsson B; Stockelberg D; Wadenvik H
    Bone Marrow Transplant; 2002 Dec; 30(12):971-3. PubMed ID: 12476293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement.
    Cristiano G; Nanni J; Sartor C; Parisi S; Marconi G; Barbato F; Arpinati M; Bonifazi F; Curti A; Cavo M; Paolini S; Papayannidis C
    Acta Haematol; 2021; 144(6):688-692. PubMed ID: 34130278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ponatinib: A new tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Shamroe CL; Comeau JM
    Ann Pharmacother; 2013 Nov; 47(11):1540-6. PubMed ID: 24265264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful second allogeneic stem cell transplantation in second remission induced by dasatinib in a child with Philadelphia chromosome positive acute lymphoblastic leukemia.
    Millot F; Cividin M; Brizard F; Chomel JC; Méchinaud F; Guilhot F
    Pediatr Blood Cancer; 2009 Jul; 52(7):891-2. PubMed ID: 19202569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Molecular Remission Achieved by Antibody Anti-CD22 and Ponatinib in a Patient Affected by Ph'+ Acute Lymphoblastic Leukemia Relapsed after Second Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report.
    Pirosa MC; Leotta S; Cupri A; Stella S; Martino EA; Scalise L; Sapienza G; Calafiore V; Mauro E; Spadaro A; Vigneri P; Di Raimondo F; Milone G
    Chemotherapy; 2018; 63(4):220-224. PubMed ID: 30372691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic and preemptive therapy with dasatinib after hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Caocci G; Vacca A; Ledda A; Murgia F; Piras E; Greco M; Arras M; Atzeni S; Littera R; La Nasa G
    Biol Blood Marrow Transplant; 2012 Apr; 18(4):652-4. PubMed ID: 22240733
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute myelofibrosis terminating in acute lymphoblastic leukemia: case report and review of the literature.
    Dunphy CH; Kitchen S; Saravia O; Velasquez WS
    Am J Hematol; 1996 Jan; 51(1):85-9. PubMed ID: 8571944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocytic aleukemic leukemia cutis.
    Török L; Lueff S; Garay G; Tápai M
    J Eur Acad Dermatol Venereol; 1999 Jul; 13(1):54-8. PubMed ID: 10565632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current treatment of philadelphia chromosome-positive acute lymphoblastic leukemia].
    Sugiura I
    Rinsho Ketsueki; 2014 Oct; 55(10):1972-80. PubMed ID: 25297762
    [No Abstract]   [Full Text] [Related]  

  • 20. Maintenance therapy with dasatinib after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Teng CL; Yu JT; Chen HC; Hwang WL
    Ann Hematol; 2013 Aug; 92(8):1137-9. PubMed ID: 23307602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.